Each morning we go to work finding solutions for the millions of people suffering from the debilitating effects of heart failure, one of today’s leading causes of death.

Introducing AccuCinch®

An innovative therapy that opens up treatment possibilities for patients with heart failure, also known as congestive heart failure or CHF.

The AccuCinch Ventricular Restoration System has been granted Breakthrough Device Designation by the FDA

CAUTION – Investigational device.  Limited by United States law to investigational use.

Click links to play in additional languages: French, Lithuanian, Dutch, German, Italian, Spanish.


If you’re already living with common signs and symptoms of heart failure, including extreme fatigue, difficulty breathing, or memory loss, and have exhausted other treatments, the AccuCinch Ventricular Restoration System may be a good option.


Early feasibility clinical data has demonstrated the potential of the AccuCinch Ventricular Restoration System to improve quality of life (QoL), improve functional capacity and initiate a process of reverse remodeling in patients who have heart failure with reduced ejection fraction (HFrEF).

We are currently enrolling patients in a randomized, controlled clinical trial called The CORCINCH-HF Study to further evaluate the benefits of the AccuCinch System for heart failure patients.

Innovating as a Team

At Ancora Heart, we are building upon decades of experience to help people with heart failure live more comfortably.

To Learn More